Theravalues Corporation is a leading biotechnology innovator in the healthcare and supplement industry. Based in Tokyo, Japan, it endeavors to offer value-driven consumer products, nutraceuticals and pharmaceuticals by using its scientific knowledge and R&D technologies.
Its major two products, Theracurmin - one of the most advanced forms of curcumin in the marketplace - and EMIQ - highly bioavailable quercetin glucosides - have been studied in various areas in human clinical trials and shown positive results with significant differences.
Kioicho Bldg. 1 Fl.
Contact: Marie Kanatani